Director and Chairman Emeritus Peter C. Farrell filed a statement of changes in beneficial ownership with the SEC on November 13, 2026, reporting a tax-withholding disposition of ResMed Inc. common stock on November 11, 2026.
Key Highlights
- Reporting person: Peter C. Farrell, identified as a director and Chairman Emeritus of ResMed Inc. (NYSE:RMD)
- Transaction type: Code "F" disposition, representing shares withheld by the issuer for tax obligations upon vesting of Restricted Stock Units
- Shares disposed: 169.142 shares of ResMed Common Stock at a price of $234.11 per share on November 11, 2026
- RSU grant date: The underlying Restricted Stock Units were originally granted on November 20, 2025, according to the filing's explanation of responses
- Remaining beneficial ownership: Following the transaction, Farrell directly held 51,634 shares of ResMed Common Stock
- Filing form: Filed by one reporting person; no derivative securities transactions were reported in Table II
Peter Farrell's November 2026 RSU Tax Withholding at ResMed
According to the filing, the transaction recorded was a Code "F" disposition, meaning shares were surrendered directly to the issuer to satisfy tax withholding obligations that arose upon the vesting of Restricted Stock Units. The filing specifies that those RSUs were granted on November 20, 2025. ResMed Inc. is a medical device company focused on sleep and respiratory health, and Farrell's role as Chairman Emeritus reflects a long-standing association with the company's governance.
The 169.142 shares were disposed of at $234.11 per share on November 11, 2026, with the filing submitted two days later on November 13, 2026. Following this disposition, Farrell's direct beneficial ownership stood at 51,634 shares of ResMed Common Stock, as reported in Table I of the filing. No derivative securities were acquired or disposed of, and Table II contained no reportable transactions. The filing was made solely by Farrell as one reporting person, and ownership is listed as direct with no indirect holdings noted in this filing.
What Was Disclosed
The filing disclosed a single tax-withholding disposition of 169.142 shares of ResMed Common Stock by Director and Chairman Emeritus Peter C. Farrell at $234.11 per share on November 11, 2026, leaving him with 51,634 directly held shares.



Please wait processing your request...